Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin

Friedreich's ataxia is due to loss of function mutations in the gene encoding frataxin (FRDA). Frataxin is a protein of unknown function. In situ hybridization analyses revealed that mouse frataxin expression correlates wed with the main site of neurodegeneration, but the expression pattern is broader than expected from the pathology of the disease. Frataxin mRNA is predominantly expressed in tissues with a high metabolic rate, including liver, kidney, brown fat and heart. We found that mouse and yeast frataxin homologues contain a potential mitochondrial targeting sequence in their N-terminal domains and that disruption of the yeast gene results in mitochondrial dysfunction. Finally, tagging experiments demonstrate that human frataxin co-localizes with a mitochondrial protein. Friedreich's ataxia is therefore a mitochondrial disease caused by a mutation in the nuclear genome.

[1]  M. Kanehisa,et al.  A knowledge base for predicting protein localization sites in eukaryotic cells , 1992, Genomics.

[2]  B. Barrell,et al.  Life with 6000 Genes , 1996, Science.

[3]  V. Schreiber,et al.  A eukaryotic expression vector for the study of nuclear localization signals. , 1994, Gene.

[4]  R. Rothstein.  Targeting, disruption, replacement, and allele rescue: integrative DNA transformation in yeast. , 1991, Methods in enzymology.

[5]  P. Philippsen,et al.  New heterologous modules for classical or PCR‐based gene disruptions in Saccharomyces cerevisiae , 1994, Yeast.

[6]  R. Williamson,et al.  Friedreich's ataxia: a defect in signal transduction? , 1995, Human molecular genetics.

[7]  M. Coutts,et al.  The mouse homologue of the human acidic ribosomal phosphoprotein PO: a highly conserved polypeptide that is under translational control. , 1989, Nucleic acids research.

[8]  B. Dobberstein,et al.  Common Principles of Protein Translocation Across Membranes , 1996, Science.

[9]  P. Menozzi,et al.  Incidence of Friedreich ataxia in Italy estimated from consanguineous marriages. , 1983, American journal of human genetics.

[10]  M. Pandolfo,et al.  Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. , 1997, Science.

[11]  M. Koenig,et al.  Ataxia with isolated vitamin E deficiency is caused by mutations in the α–tocopherol transfer protein , 1995, Nature Genetics.

[12]  R. Williamson,et al.  The Friedreich's ataxia gene encodes a novel phosphatidylinositol–4–phosphate 5–kinase , 1996, Nature Genetics.

[13]  D. Borchelt,et al.  An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria , 1995, Neuron.

[14]  H. Skre,et al.  Friedreich's ataxia in Western Norway , 1975, Clinical genetics.

[15]  D. Wallace,et al.  Mitochondrial DNA mutations in human degenerative diseases and aging. , 1995, Biochimica et biophysica acta.

[16]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[17]  A Dürr,et al.  Clinical and genetic abnormalities in patients with Friedreich's ataxia. , 1996, The New England journal of medicine.

[18]  B. Halliwell,et al.  Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? , 1994, The Lancet.

[19]  T. Gibson,et al.  Friedreich's ataxia protein: phylogenetic evidence for mitochondrial dysfunction , 1996, Trends in Neurosciences.

[20]  P. Patel,et al.  Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion , 1996, Science.

[21]  A. Harding.  Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. , 1981, Brain : a journal of neurology.

[22]  P. Rigby,et al.  High efficiency gene transfer into mammalian cells. , 1984, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.